Pursuant to the Securities and Exchange Board of India Circular dated December 31, 2024, read with relevant stock exchange circular, Zenotech Laboratories has submitted the Integrated Filing (Financial) for the quarter and financial year ended March 31, 2025, as follows: A) Financial Results – attached as Annexure A B) Statement on deviation/variation in utilisation of funds raised - Not Applicable C) Outstanding default on loans and debt securities -Not Applicable D) Related Party Transactions for the half year ended March 31, 2025 - attached as Annexure B.
The above information is a part of company’s filings submitted to BSE.
